CD274 and hepatocellular carcinoma: Although there are still imperfections in our study, we have furthered our understanding of the biological function of HBV-DNA-Pol and discovered a novel mechanism for its regulation of PD-L1, which also brings new ideas to the clinic to improve therapeutic strategies for hepatocellular carcinoma.